| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 109.97B | 108.04B | 109.11B | 106.12B | 99.08B | 89.58B |
| Gross Profit | 22.30B | 21.78B | 23.91B | 24.47B | 21.32B | 21.56B |
| EBITDA | 10.08B | 9.16B | 12.15B | 12.19B | 10.10B | 10.13B |
| Net Income | 4.94B | 4.86B | 6.67B | 7.39B | 4.89B | 5.58B |
Balance Sheet | ||||||
| Total Assets | 145.78B | 164.17B | 146.13B | 143.86B | 127.18B | 117.56B |
| Cash, Cash Equivalents and Short-Term Investments | 35.89B | 34.27B | 41.34B | 39.87B | 34.22B | 33.45B |
| Total Debt | 3.33B | 3.22B | 3.56B | 3.49B | 3.57B | 4.12B |
| Total Liabilities | 52.36B | 53.53B | 51.67B | 52.27B | 48.07B | 42.64B |
| Stockholders Equity | 93.32B | 110.51B | 94.36B | 88.66B | 76.00B | 71.96B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.72B | 3.35B | 7.29B | 4.53B | 8.04B |
| Operating Cash Flow | 0.00 | 5.75B | 7.24B | 12.96B | 8.32B | 10.64B |
| Investing Cash Flow | 0.00 | -8.74B | -2.00B | -5.95B | -2.89B | -3.75B |
| Financing Cash Flow | 0.00 | -3.49B | -5.44B | -2.54B | -5.61B | -3.83B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥401.13B | 9.42 | 9.59% | 3.91% | -2.06% | 46.42% | |
65 Neutral | ¥143.21B | 10.40 | ― | 3.21% | -0.11% | 457.37% | |
63 Neutral | ¥95.30B | 20.97 | ― | 2.25% | -0.98% | -26.01% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
58 Neutral | ¥2.47B | 40.23 | ― | 4.05% | -5.56% | -78.65% | |
55 Neutral | ¥300.16B | -3.18 | 9.34% | 4.27% | -1.18% | -78.57% | |
46 Neutral | ¥145.59B | -14.77 | 4.24% | 3.76% | -0.20% | -276.01% |